Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Epigenetic Inactivation of Notch Signaling Target Genes HES in B Cell Acute Lymphoblastic Leukemia.

Shaoqing Kuang, Patrick Zweidler-McKay, MD, PhD, Hui Yang, Zhi Hong Fang, PhD, Weigang Tong, MD, PhD, Guillermo Garcia-Manero, MD

Blood (2008) 112 (11): 3372.

https://doi.org/10.1182/blood.V112.11.3372.3372

Published: 2008

Journal Articles

The Combination of a Histone Deacetylase (HDAC) Inhibitor with the BCL-2 Inhibitor GX15-070 Has Synergistic Antileukemia Effect by Inducing Both Apoptotic and Autophagic Pathways.

Yue Wei, PhD, Tapan Kadia, MD, Weigang Tong, MD, PhD, Susan O’Brien, MD, Jean Viallet, MD, Guillermo Garcia-Manero, MD

Blood (2008) 112 (11): 1633.

https://doi.org/10.1182/blood.V112.11.1633.1633

Published: 2008

Journal Articles

Identification of Multiple Promoter Associated CpG Islands Commonly Methylated in Both Acute Lymphocytic Leukemia (ALL) and Chronic Lymphocytic Leukemia(CLL) Using Novel Genome-Wide Microarray Technique: Implications for Common Primordial Molecular Pathways in Lymphoid Leukemias.

Weigang Tong, MD, PhD, Shao-Qing Kuang, MD, PhD, William Wierda, MD, PhD, Michael J. Keating, MD, Guillermo Garcia-Manero, MD

Blood (2008) 112 (11): 2263.

https://doi.org/10.1182/blood.V112.11.2263.2263

Published: 2008

Journal Articles

Genome-Wide Identification of Aberrant Promoter Associated CpG Island Methylation in Acute Lymphoblastic Leukemia.

Shao-qing Kuang, MD, PhD, Weigang Tong, MD, PhD, Hui Yang, MD, PhD, Mathew K. Lee, Zhi-Hong Fang, PhD, Jeroslav Jelinek, MD, PhD, Jean-Pierre Issa, MD, Guillermo Garcia-Manero, MD

Blood (2007) 110 (11): 2127.

https://doi.org/10.1182/blood.V110.11.2127.2127

Published: 2007

Journal Articles

Eph Receptor Tyrosine Kinases and Ephrin Ligands Are Epigenetically Inactivated in Acute Lymphoblastic Leukemia and Are Potential New Tumor Suppressor Genes in Human Leukemia.

Shao-qing Kuang, MD, PhD, Zhi-Hong Fang, PhD, Gonzalo Lopez, Weigang Tong, MD, PhD, Hui Yang, MD, PhD, Guillermo Garcia-Manero, MD

Blood (2007) 110 (11): 2128.

https://doi.org/10.1182/blood.V110.11.2128.2128

Published: 2007

NARROW

Epigenetic Inactivation of Notch Signaling Target Genes HES in B Cell Acute Lymphoblastic Leukemia.

The Combination of a Histone Deacetylase (HDAC) Inhibitor with the BCL-2 Inhibitor GX15-070 Has Synergistic Antileukemia Effect by Inducing Both Apoptotic and Autophagic Pathways.

Identification of Multiple Promoter Associated CpG Islands Commonly Methylated in Both Acute Lymphocytic Leukemia (ALL) and Chronic Lymphocytic Leukemia(CLL) Using Novel Genome-Wide Microarray Technique: Implications for Common Primordial Molecular Pathways in Lymphoid Leukemias.

Genome-Wide Identification of Aberrant Promoter Associated CpG Island Methylation in Acute Lymphoblastic Leukemia.

Eph Receptor Tyrosine Kinases and Ephrin Ligands Are Epigenetically Inactivated in Acute Lymphoblastic Leukemia and Are Potential New Tumor Suppressor Genes in Human Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Epigenetic Inactivation of Notch Signaling Target Genes HES in B Cell Acute Lymphoblastic Leukemia.

The Combination of a Histone Deacetylase (HDAC) Inhibitor with the BCL-2 Inhibitor GX15-070 Has Synergistic Antileukemia Effect by Inducing Both Apoptotic and Autophagic Pathways.

Identification of Multiple Promoter Associated CpG Islands Commonly Methylated in Both Acute Lymphocytic Leukemia (ALL) and Chronic Lymphocytic Leukemia(CLL) Using Novel Genome-Wide Microarray Technique: Implications for Common Primordial Molecular Pathways in Lymphoid Leukemias.

Genome-Wide Identification of Aberrant Promoter Associated CpG Island Methylation in Acute Lymphoblastic Leukemia.

Eph Receptor Tyrosine Kinases and Ephrin Ligands Are Epigenetically Inactivated in Acute Lymphoblastic Leukemia and Are Potential New Tumor Suppressor Genes in Human Leukemia.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only